Toronto - Delayed Quote CAD

Microbix Biosystems Inc. (MBX.TO)

0.3500
+0.0100
+(2.94%)
At close: May 16 at 3:59:31 PM EDT
Loading Chart for MBX.TO
  • Previous Close 0.3400
  • Open 0.3500
  • Bid 0.3450 x --
  • Ask 0.3500 x --
  • Day's Range 0.3450 - 0.3500
  • 52 Week Range 0.2900 - 0.5500
  • Volume 15,418
  • Avg. Volume 113,364
  • Market Cap (intraday) 49.573M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 35.00
  • EPS (TTM) 0.0100
  • Earnings Date Aug 5, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 2, 1999
  • 1y Target Est 0.80

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

www.microbix.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: MBX.TO

View More

Performance Overview: MBX.TO

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MBX.TO
14.63%
S&P/TSX Composite index (^GSPTSE)
5.49%

1-Year Return

MBX.TO
0.00%
S&P/TSX Composite index (^GSPTSE)
16.47%

3-Year Return

MBX.TO
22.22%
S&P/TSX Composite index (^GSPTSE)
28.53%

5-Year Return

MBX.TO
0.00%
S&P/TSX Composite index (^GSPTSE)
77.42%

Compare To: MBX.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MBX.TO

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    49.57M

  • Enterprise Value

    42.97M

  • Trailing P/E

    25.00

  • Forward P/E

    34.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.09

  • Price/Book (mrq)

    1.72

  • Enterprise Value/Revenue

    1.87

  • Enterprise Value/EBITDA

    9.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.89%

  • Return on Assets (ttm)

    3.27%

  • Return on Equity (ttm)

    5.32%

  • Revenue (ttm)

    22.72M

  • Net Income Avi to Common (ttm)

    1.56M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.54M

  • Total Debt/Equity (mrq)

    17.22%

  • Levered Free Cash Flow (ttm)

    991.76k

Research Analysis: MBX.TO

View More

Company Insights: MBX.TO

Research Reports: MBX.TO

View More

People Also Watch